The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study

oleh: Jade N. Young, BS, Hannah Verma, BA, Nour El Kashlan, MD, Dina Poplausky, BA, Angela J. Lamb, MD, Emma Guttman-Yassky, MD, PhD, Nicholas Gulati, MD, PhD

Format: Article
Diterbitkan: Elsevier 2024-01-01

Deskripsi

Subjek

biologics; cirAE; cutaneous immune-related adverse event; immune checkpoint inhibitor; immunotherapy; oncodermatology